NOS2 and pulmonary arterial hypertension: Impaired bioavailability of endothelium-derived NO, endothelial dysfunction, reduced expression and/or activity of key regulators of the pulmonary circulation tone (endothelial NO synthase (eNOS) and inducible NO synthase (iNOS)), all contribute to the pathogenesis/pathophysiology of PAH [229].